Open Access

SOX7 is involved in polyphyllin D-induced G0/G1 cell cycle arrest through down-regulation of cyclin D1


Cite

1. R. L. Siegel, K. D. Miller and A. Jemal, Cancer Statistics, 2017, CA Cancer J. Clin.67 (2017) 7–30; https://doi.org/10.3322/caac.2138710.3322/caac.2138728055103Search in Google Scholar

2. L. G. Gomella, Prostate cancer statistics: anything you want them to be, Can. J. Urol.24 (2017) 8603–8604; https://www.canjurol.com/html/free-articles/V24I1_03_FREE_Editorial_Feb17.pdfSearch in Google Scholar

3. S. Watanabe, T. Suzuki, F. Hara, T. Yasui, N. Uga and A. Naoe, Polyphyllin D, a steroidal saponin in Paris polyphylla, induces apoptosis and necroptosis cell death of neuroblastoma cells, Pediatr. Surg. Int.33 (2017) 713–719; https://doi.org/10.1007/s00383-017-4069-410.1007/s00383-017-4069-428260192Search in Google Scholar

4. D. D. Ma, H. X. Lu, L. S. Xu and W. Xiao, Polyphyllin D exerts potent anti-tumour effects on Lewis cancer cells under hypoxic conditions, J. Int. Med. Res.37 (2009) 631–640; https://doi.org/10.1177/14732300090370030510.1177/14732300090370030519589245Search in Google Scholar

5. C. Yang, H. Cai and X. Meng, Polyphyllin D induces apoptosis and differentiation in K562 human leukemia cells, Int. Immunopharmacol.36 (2016) 17–22; https://doi.org/10.1016/j.intimp.2016.04.01110.1016/j.intimp.2016.04.01127104314Search in Google Scholar

6. E. Al Sawah, D. C. Marchion, Y. Xiong, I. J. Ramirez, F. Abbasi, B. M. Boac, S. H. Bush, N. Bou Zgheib, E. C. McClung, B. R. Khulpateea, A. Berry, A. Hakam, R. M. Wenham, J. M. Lancaster and P. L. Judson, The Chinese herb polyphyllin D sensitizes ovarian cancer cells to cisplatin-induced growth arrest, J. Cancer Res. Clin. Oncol.141 (2015) 237–242; https://doi.org/10.1007/s00432-014-1797-x10.1007/s00432-014-1797-x25164128Search in Google Scholar

7. L. Wu, Q. Li and Y. Liu, Polyphyllin D induces apoptosis in K562/A02 cells through G2/M phase arrest, J. Pharm. Pharmacol.66 (2014) 713–721; https://doi.org/10.1111/jphp.1218810.1111/jphp.1218824325805Search in Google Scholar

8. M. Francois, P. Koopman and M. Beltrame, SoxF genes: Key players in the development of the cardio-vascular system, Int. J. Biochem. Cell Biol.42 (2010) 445–448; https://doi.org/10.1016/j.biocel.2009.08.01710.1016/j.biocel.2009.08.01719733255Search in Google Scholar

9. A. Gandillet, A. G. Serrano, S. Pearson, A. L. M. Lie, G. Lacaud and V. Kouskoff, SOX7-sustained expression alters the balance between proliferation and differentiation of hematopoietic progenitors at the onset of blood specification, Blood114 (2009) 4813–4822; https://doi.org/10.1182/blood-2009-06-22629010.1182/blood-2009-06-22629019801444Search in Google Scholar

10. T. J. Nelson, A. Chiriac, R. S. Faustino, R. J. Crespo-Diaz, A. Behfar and A. Terzic, Lineage specification of Flk-1+ progenitors is associated with divergent SOX7 expression in cardiopoiesis, Differentiation77 (2009) 248–255; https://doi.org/10.1016/j.diff.2008.10.01210.1016/j.diff.2008.10.012270144319272523Search in Google Scholar

11. J. Savage, A. J. Conley, A. Blais and I. S. Skerjanc, SOX15 and SOX7 differentially regulate the myogenic program in P19 cells, Stem Cells27 (2009) 1231–1243; https://doi.org/10.1002/stem.5710.1002/stem.5719489079Search in Google Scholar

12. F. Shen, W. S. Cai, Z. Feng, J. L. Li, J. W. Chen, J. Cao and B. Xu, MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression, Tumour Biol.36 (2015) 1913–1921; https://doi.org/10.1007/s13277-014-2794-z10.1007/s13277-014-2794-z25407488Search in Google Scholar

13. P. Wang, D. Chen, H. Ma and Y. Li, LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis, Oncol. Targets Ther.10 (2017) 5137–5149; https://doi.org/10.2147/OTT.S14642310.2147/OTT.S146423566184529123412Search in Google Scholar

14. Y. Wang, C. Du, N. Zhang, M. Li, Y. Liu, M. Zhao, F. Wang and F. Luo, TGF-beta1 mediates the effects of aspirin on colonic tumor cell proliferation and apoptosis, Oncol. Lett.15 (2018) 5903–5909; https://doi.org/10.3892/ol.2018.804710.3892/ol.2018.8047584067529552221Search in Google Scholar

15. J. Wang, S. Zhang, J. Wu, Z. Lu, J. Yang, H. Wu, H. Chen, B. Lin and T. Cao, Clinical significance and prognostic value of SOX7 expression in liver and pancreatic carcinoma, Mol. Med. Rep.16 (2017) 499–506; https://doi.org/10.3892/mmr.2017.666010.3892/mmr.2017.6660548209828586005Search in Google Scholar

16. M. Yang, G. Cui, M. Ding, W. Yang, Y. Liu, D. Dai and L. Chen, miR-935 promotes gastric cancer cell proliferation by targeting SOX7, Biomed. Pharmacother.79 (2016) 153–158; https://doi.org/10.1016/j.biopha.2016.01.01110.1016/j.biopha.2016.01.01127044823Search in Google Scholar

17. L. Guo, D. Zhong, S. Lau, X. Liu, X. Y. Dong, X. Sun, V. W. Yang, P. M. Vertino, C. S. Moreno, V. Varma, J. T. Dong and W. Zhou, Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells, Mol. Cancer Res.6 (2008) 1421–1430; https://doi.org/10.1158/1541-7786.MCR-07-217510.1158/1541-7786.MCR-07-2175265285918819930Search in Google Scholar

18. B. Zheng, Q. Wu, K. Zhou, Gang. W. Y. Ren, H. Qi, W. Zhu and G. Weng, Mechanisms and effects of transcription factor SOX7 on the biological activity of the prostate cancer PC-3 cells, J. Wenzhou Medical University.47 (2017) 678–682; https://doi.org/10.3969/j.issn.2095-9400.2017.09.011Search in Google Scholar

19. C. Xiuju, W. Zhen and S. Yanchao, SOX7 inhibits tumor progression of glioblastoma and is regulated by miRNA-24, Open Med. (Wars).11 (2016) 133–137; https://doi.org/10.1515/med-2016-002610.1515/med-2016-0026532981328352781Search in Google Scholar

20. S. Huang, P. Cui, S. Lin, X. Yao, X. Wang, Y. Ren and G. Weng, The transcription factor creb is involved in sorafenib-inhibited renal cancer cell proliferation, migration and invasion, Acta Pharm.68 (2018) 497–506; https://doi.org/10.2478/acph-2018-003310.2478/acph-2018-003331259702Search in Google Scholar

21. W. Liu, R. Ning, R. N. Chen, X. F. Huang, Q. S. Dai, J. H. Hu, Y. W. Wang, L. L. Wu, J. Xiong, G. Hu, Q. L. Guo, J. Yang and H. Wang, Aspafilioside B induces G2/M cell cycle arrest and apoptosis by up-regulating H-Ras and N-Ras via ERK and p38 MAPK signaling pathways in human hepatoma HepG2 cells, Mol. Carcinog.55 (2016) 440–457; https://doi.org/10.1002/mc.2229310.1002/mc.2229325683703Search in Google Scholar

22. M. E. O’Callaghan, E. Raymond, J. Campbell, A. D. Vincent, K. Beckmann, D. Roder, S. Evans, J. McNeil, J. Millar, J. Zalcberg, M. Borg and K. Moretti, Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity, Prostate Cancer Prostatic Dis.20 (2017) 378–388; https://doi.org/10.1038/pcan.2017.2810.1038/pcan.2017.2828585573Search in Google Scholar

23. R. C. Ong, J. Lei, R. K. Lee, J. Y. Cheung, K. P. Fung, C. Lin, H. P. Ho, B. Yu, M. Li and S. K. Kong, Polyphyllin D induces mitochondrial fragmentation and acts directly on the mitochondria to induce apoptosis in drug-resistant HepG2 cells, Cancer Lett.261 (2008) 158–164; https://doi.org/10.1016/j.canlet.2007.11.00510.1016/j.canlet.2007.11.00518082940Search in Google Scholar

24. Y. Luo, J. Hurwitz and J. Massague, Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1, Nature375 (1995) 159–161; https://doi.org/10.1038/375159a010.1038/375159a07753174Search in Google Scholar

25. M. P. Swaffer, A. W. Jones, H. R. Flynn, A. P. Snijders and P. Nurse, CDK Substrate Phosphorylation and Ordering the Cell Cycle, Cell.167 (2016) 1750–1761 e1716; https://doi.org/10.1016/j.cell.2016.11.03410.1016/j.cell.2016.11.034516175127984725Search in Google Scholar

26. U. Galderisi, F. P. Jori and A. Giordano, Cell cycle regulation and neural differentiation, Oncogene22 (2003) 5208–5219; https://doi.org/10.1038/sj.onc.120655810.1038/sj.onc.120655812910258Search in Google Scholar

27. D. Ye, H. Luo, Z. Lai, L. Zou, L. Zhu, J. Mao, T. Jacob, W. Ye, L. Wang and L. Chen, ClC-3 Chloride Channel Proteins Regulate the Cell Cycle by Up-regulating cyclin D1-CDK4/6 through Suppressing p21/p27 Expression in Nasopharyngeal Carcinoma Cells, Sci. Rep.6 (2016) 30276; https://doi.org/10.1038/srep3027610.1038/srep30276495900327451945Search in Google Scholar

28. H. Liu, E. Mastriani, Z. Q. Yan, S. Y. Yin, Z. Zeng, H. Wang, Q. H. Li, H. Y. Liu, X. Wang, H. X. Bao, Y. J. Zhou, J. J. Kou, D. Li, T. Li, J. Liu, Y. Liu, L. Yin, L. Qiu, L. Gong and S. L. Liu, SOX7 co-regulates Wnt/beta-catenin signaling with Axin-2: both expressed at low levels in breast cancer, Sci. Rep.6 (2016) 26136; https://doi.org/10.1038/srep2613610.1038/srep26136487056627188720Search in Google Scholar

29. D. Chen, J. Li, S. Li, P. Han, N. Li, Y. Wang and S. Du, miR-184 promotes cell proliferation in tongue squamous cell carcinoma by targeting SOX7, Oncol. Lett.16 (2018) 2221–2228; https://doi.org/10.3892/ol.2018.890610.3892/ol.2018.8906603641430008922Search in Google Scholar

30. H. Liu, Z. Q. Yan, B. Li, S. Y. Yin, Q. Sun, J. J. Kou, D. Ye, K. Ferns, H. Y. Liu and S. L. Liu, Reduced expression of SOX7 in ovarian cancer: a novel tumor suppressor through the Wnt/beta-catenin signaling pathway, J, Ovarian Res.7 (2014) 87; https://doi.org/10.1186/s13048-014-0087-110.1186/s13048-014-0087-1417277925297608Search in Google Scholar

31. L. Wang, Y. Fan, L. Zhang, L. Li, G. Kuang, C. Luo, C. Li, T. Xiang, Q. Tao, Q. Zhang and J. Ying, Classic SRY-box protein SOX7 functions as a tumor suppressor regulating WNT signaling and is methylated in renal cell carcinoma, FASEB J.33 (2019) 254–263; https://doi.org/10.1096/fj.201701453RR10.1096/fj.201701453RR29957056Search in Google Scholar

32. D. W. Chan, C. S. Mak, T. H. Leung, K. K. Chan and H. Y. Ngan, Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer, Oncotarget.3 (2012) 1546–1556; https://doi.org/10.18632/oncotarget.66710.18632/oncotarget.667368149323295859Search in Google Scholar

33. X. Zhou, S. Y. Huang, J. X. Feng, Y. Y. Gao, L. Zhao, J. Lu, B. Q. Huang and Y. Zhang, SOX7 is involved in aspirin-mediated growth inhibition of human colorectal cancer cells, World J. Gastroenterol.17 (2011) 4922–4927; https://doi.org/10.3748/wjg.v17.i44.492210.3748/wjg.v17.i44.4922323563722171135Search in Google Scholar

34. K. Vermeulen, D. R. V. Bockstaele and Z. N. Berneman, The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer, Cell Proliferation36 (2003) 131–149; http://dx.doi.org/10.1046/j.1365-2184.2003.00266.x10.1046/j.1365-2184.2003.00266.x649672312814430Search in Google Scholar

35. C. Wang, Y. Guo, J. Wang and Z. Min, The suppressive role of SOX7 in hepatocarcinogenesis, PLoS One.9 (2014) e97433; https://doi.org/10.1371/journal.pone.009743310.1371/journal.pone.0097433401631124816720Search in Google Scholar

36. X. Liu, J. Li, Z. Yu, J. Li, R. Sun and Q. Kan, miR-935 promotes liver cancer cell proliferation and migration by targeting SOX7, Oncol. Res.25 (2017) 427–435; https://doi.org/10.3727/096504016X1474730020737410.3727/096504016X14747300207374784107127697092Search in Google Scholar

eISSN:
1846-9558
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Pharmacy, other